MX2013008635A - Mejoras de y relacionadas con composiciones. - Google Patents

Mejoras de y relacionadas con composiciones.

Info

Publication number
MX2013008635A
MX2013008635A MX2013008635A MX2013008635A MX2013008635A MX 2013008635 A MX2013008635 A MX 2013008635A MX 2013008635 A MX2013008635 A MX 2013008635A MX 2013008635 A MX2013008635 A MX 2013008635A MX 2013008635 A MX2013008635 A MX 2013008635A
Authority
MX
Mexico
Prior art keywords
preserved
relating
compositions
solutions
constipation
Prior art date
Application number
MX2013008635A
Other languages
English (en)
Other versions
MX360450B (es
Inventor
Chris Seldon
Dawn Padfield
Frances Morrissey
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1101666.4A external-priority patent/GB201101666D0/en
Priority claimed from GBGB1101738.1A external-priority patent/GB201101738D0/en
Priority claimed from GBGB1200637.5A external-priority patent/GB201200637D0/en
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of MX2013008635A publication Critical patent/MX2013008635A/es
Publication of MX360450B publication Critical patent/MX360450B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invención se refiere a soluciones acuosas que comprenden polietilenglicol para uso como un medicamento, particularmente en el tratamiento de estreñimiento y retención fecal. Las soluciones pueden conservarse para eliminar el crecimiento de organismos microbianos. También se proporcionan kits que comprenden una solución acuosa conservada y una tableta o cápsula separada que comprende electrolitos.
MX2013008635A 2011-01-31 2012-01-31 Mejoras de y relacionadas con composiciones. MX360450B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1101666.4A GB201101666D0 (en) 2011-01-31 2011-01-31 Improvements in and relating to compositions
GBGB1101738.1A GB201101738D0 (en) 2011-02-01 2011-02-01 Improvements in and relating to compositions
GBGB1200637.5A GB201200637D0 (en) 2012-01-13 2012-01-13 Improvements in and relating to compositions
PCT/GB2012/050195 WO2012104617A1 (en) 2011-01-31 2012-01-31 Improvements in and relating to compositions

Publications (2)

Publication Number Publication Date
MX2013008635A true MX2013008635A (es) 2013-11-04
MX360450B MX360450B (es) 2018-11-01

Family

ID=45563438

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008635A MX360450B (es) 2011-01-31 2012-01-31 Mejoras de y relacionadas con composiciones.

Country Status (16)

Country Link
EP (2) EP2862566B1 (es)
JP (2) JP2014504628A (es)
KR (1) KR101852502B1 (es)
CN (2) CN103458874A (es)
AU (1) AU2012213180B2 (es)
BR (1) BR112013019418B1 (es)
DE (1) DE202012013349U1 (es)
DK (1) DK2862566T3 (es)
EA (1) EA028925B1 (es)
ES (1) ES2914034T3 (es)
HR (1) HRP20220691T1 (es)
MX (1) MX360450B (es)
PL (1) PL2862566T3 (es)
PT (1) PT2862566T (es)
WO (1) WO2012104617A1 (es)
ZA (1) ZA201305342B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
ES2909386T3 (es) 2012-09-11 2022-05-06 Norgine Bv Composiciones que comprenden polietilenglicol y sulfatos de metales alcalinos o alcalinotérreos para su uso como composiciones de limpieza de colon
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
CN107787223A (zh) * 2015-06-22 2018-03-09 西梯茜生命工学股份有限公司 肠道清洁用泻剂组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60237384D1 (de) * 2001-10-29 2010-09-30 Ajinomoto Kk Lösung zur darmreinigung
US20060029570A1 (en) * 2003-11-17 2006-02-09 Braintree Laboratories, Inc. Therapeutic PEG solution concentrate
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
JP5276435B2 (ja) * 2005-05-06 2013-08-28 セイリックス ファーマシューティカルズ， インコーポレイティッド ポリエチレングリコールの結腸の下剤組成物
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions

Also Published As

Publication number Publication date
BR112013019418A2 (es) 2017-08-29
JP6498250B2 (ja) 2019-04-10
ZA201305342B (en) 2014-12-23
CN103458874A (zh) 2013-12-18
HRP20220691T1 (hr) 2022-07-08
EP2862566B1 (en) 2022-03-09
MX360450B (es) 2018-11-01
CN107260661A (zh) 2017-10-20
WO2012104617A1 (en) 2012-08-09
EA201300882A1 (ru) 2014-01-30
PT2862566T (pt) 2022-06-02
EP2862566A1 (en) 2015-04-22
NZ613401A (en) 2016-03-31
PL2862566T3 (pl) 2022-06-20
DE202012013349U1 (de) 2016-06-27
EP2670391A1 (en) 2013-12-11
DK2862566T3 (da) 2022-05-16
ES2914034T3 (es) 2022-06-07
BR112013019418B1 (pt) 2022-03-29
EA028925B1 (ru) 2018-01-31
KR20140007881A (ko) 2014-01-20
KR101852502B1 (ko) 2018-04-26
AU2012213180B2 (en) 2017-04-13
JP2018035181A (ja) 2018-03-08
JP2014504628A (ja) 2014-02-24

Similar Documents

Publication Publication Date Title
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
PH12015501336A1 (en) Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
UA109464C2 (uk) Спірооксіндольні антагоністи mdm2
WO2012033789A3 (en) Treatment of diseases
EA030970B8 (ru) Композиция для восстановления функции тонкого кишечника, способы ее приготовления и применения
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
MX2013004061A (es) Analogos de ciclosporina.
IN2015DN02729A (es)
MY161601A (en) Films and compositions comprising the same
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2010149283A3 (de) Phenyloxy(thio)phenylamidbenzoxa(thia)zole
EP2583969A4 (en) NEW RHODANINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS WITH THE RHODANIN DERIVATIVES AS ACTIVE AGENTS
MX2013004062A (es) Analogos de ciclosporina.
MX2013008635A (es) Mejoras de y relacionadas con composiciones.
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
WO2013055889A3 (en) Implantable scaffolds and methods of use
MX2013007055A (es) Derivados de sanglifehrina y metodos para su produccion.
WO2012108748A3 (ko) 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
AR089615A1 (es) Peptidos antimicrobianos, composiciones que los comprenden y usos
MX2013009456A (es) Compuestos de azufre aromaticos sustituidos y metodos para su uso.
TN2011000352A1 (en) New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
GB2491084A (en) Compounds for the treatment of renal cell carcinoma
UA92273C2 (ru) Использование углекислотного экстракта хмеля в качестве активной субстанции в фармацевтических композициях с противомикробным действием
UA92274C2 (ru) Использование спиртового экстракта хмеля в качестве активной субстанции в фармацевтических композициях с противомикробным действием
UA99024C2 (uk) Засіб рослинного походження для лікування та профілактики захворювань нирок і сечовивідної системи

Legal Events

Date Code Title Description
FG Grant or registration